Prof. PeptideProf. Peptide

Thymalin: Benefits, Dosage and Side Effects in 2026

Thymalin is a polypeptide complex extracted from the thymus, sold in Russia as a prescription immune medicine injected into the muscle in short courses36. Its main human report, a 6-to-8-year study of 266 older people, reported lower mortality and fewer respiratory infections1; neither it nor a COVID-19 add-on study is described as randomized2. It is not approved in the US.

Other names: thymus polypeptide complex. Related: Thymogen and Epitalon.

  • Gut Health & Immunity
  • Research-Grade

Last updated November 17, 2026 by the Prof. Peptide editorial team

What is Thymalin?

Thymalin is a polypeptide complex isolated from the thymus that regulates immune function, described as used for acute respiratory illness, chronic obstructive bronchitis and other immune conditions3. Its active parts are reported to include the dipeptides Lys-Glu and Glu-Trp5. In Russia it is a prescription product, each vial holding 10 mg of thymus polypeptides6.

What it is
A thymus polypeptide extract3.
How it's taken
Intramuscular injection on the Russian label; clinics also use subcutaneous injection678.
Half-life
No published half-life figure.
How it's dosed
Russian label: 5,000 to 20,000 mcg (5 to 20 mg) a day for 3 to 10 days6.
Research status
Prescription medicine in Russia; not approved in the US6.

Where to buy Thymalin?

Thymalin has no US prescription product. Research-grade Thymalin is sold by specialty peptide vendors for laboratory use only, with no label behind it. The vendors listed here sell it, each with Prof. Peptide's code. Each vendor name links to its Prof. Peptide page, with the vendor's catalog, testing and shipping details.

Ion Peptide

✓ Lab & COAs Verified🇺🇸 US
15% off
Ion Peptide logo

Fusion Peptide

✓ Lab & COAs Verified🇺🇸 US
15% off
Fusion Peptide logo

Peak Lab Peptides

🇺🇸 US
10% off
Peak Lab Peptides logo

Molecular Solutions Peptides: 25% off a first order automatically, plus 10% more with Prof. Peptide’s code, no end date given · checked Nov 6. All current deals

Ion Peptide: Bundle prices up to 45% off, plus 15% with Prof. Peptide’s code, no end date given · checked Nov 17. All current deals

See all 225 vendors

How much does Thymalin cost?

Thymalin's research-grade prices, read from each vendor's own store. The most common Thymalin vial is 10 mg, listed by 13 vendors, from $18.43 after the code.

Thymalin costs from $1.55 to $10.71 per mg after Prof. Peptide's code, across 16 listings from 15 vendors, with prices as of November 16, 2026; the median listing is $4.28 per mg. Listings are shown lowest first. The price on top is after the PROFPEPTIDE discount code, and the crossed-out price is the vendor's regular price.

13 mg$1.55/mg$1.82/mgSale$20.09$23.64
Real PeptidesOut of stock
10 mg$1.84/mg$2.30/mg$18.43$23.04
10 mg$1.87/mg$2.20/mgSale$18.69$21.99
10 mg$2.04/mg$2.40/mgSale$20.39$23.99
10 mg$2.94/mg$3.26/mgSale$29.37$32.63
American PeptidesOut of stock
20 mg$3.15/mg$3.50/mg$63.00$70.00
20 mg$3.63/mg$4.04/mg$72.68$80.75
10 mg$4.05/mg$4.50/mg$40.49$44.99
10 mg$4.50/mg$6.00/mg$44.99$59.99
Alpha PeptidesOut of stock
10 mg$4.55/mg$5.05/mg$45.48$50.53
LA Peptidesprice read Nov 14
10 mg$4.55/mg$7.00/mg$45.49$69.99
10 mg$4.55/mg$6.50/mg$45.50$65.00
10 mg$5.01/mg$5.90/mg$50.15$59.00
10 mg$5.53/mg$6.50/mg$55.25$65.00
10 mg$5.94/mg$6.60/mgSale$59.39$65.99
10 mg$10.71/mg$11.90/mg$107.10$119.00

Prices as of November 16, 2026; a listing read earlier shows its own date

Price trend, vendors' own listed price before any code (median per mg): $6.07 on August 18, 2026 → $4.50 on November 16, 2026. These medians come from the nightly price file, which held 11 listings on the first date and 22 listings on the last, including listings the table above leaves out (vendors excluded, retired or not re-read recently); more vendors were added over the period.

What are Thymalin's uses and reported benefits?

Thymalin is used for immune support and longevity. Clinics offer it in short courses for immune function, and its Russian label sets courses for weakened immunity; in older people its developers reported lower mortality and fewer respiratory infections, and in COVID-19 a faster fall in inflammation markers, in reports not described as randomized1269.

Clinic reports describe practice, not trial results, and one clinic notes that the evidence comes largely from a single Russian research program10.

Thymalin uses by area: clinical reports and human studies
Use areaClinical reportsHuman studies
Immune support

Clinics use it in short courses as an immune regulator; the Russian label sets a course length by how weakened immunity is689.

In COVID-19, adding Thymalin to standard care sped the fall in IL-6, C-reactive protein and D-dimer; the abstract gives no patient numbers2.

Longevity and aging

Clinics use it for healthy aging, with courses repeated after about 3 months8.

In 266 older people followed for 6 to 8 years, mortality was 2.0 to 2.1 times lower with Thymalin and 4.1 times lower in a separate group given it with Epithalamin each year for 6 years, against controls1.

Respiratory infectionsNo published clinic report for this use.

The same study reported 2.0 to 2.4 times fewer acute respiratory infections with Thymalin and Epithalamin than in controls1.

How does Thymalin work?

Thymalin's proposed mechanism is immune regulation. It is a polypeptide extract of the thymus3, which a clinic describes as approved as an immunomodulator in the USSR in 19829, and in its COVID-19 report IL-6 and C-reactive protein fell faster2. Its proposed cellular actions come from lab work, set out further down.

How is Thymalin dosed?

Thymalin's Russian label sets 5,000 to 20,000 mcg (5 to 20 mg) a day by intramuscular injection for 3 to 10 days, repeated after 1 to 6 months if needed6. Clinics most often publish 10,000 mcg (10 mg) a day for 5 to 10 days, repeated after 3 to 6 months789.

The range reported runs from 250 mcg five days a week to the label's 20,000 mcg (20 mg)789.

The clinics below are representative of the clinics that publish a dose; each row is that source's own published protocol. Thymalin is an extract, so its doses are a mass of mixed thymus polypeptides, not of one defined peptide.

SourceRouteDose as publishedSchedule and course
Russian label (Samson-Med)6Intramuscular5,000–20,000 mcg (5–20 mg) a day; 5,000–10,000 mcg (5–10 mg) for prevention3 to 10 days; repeat after 1 to 6 months if needed
Hunter Williams Health8Subcutaneous10,000 mcg (10 mg) a day5 to 10 days; repeat after 3 months if needed
AMT Care9—10,000 mcg (10 mg) a day10 days; may repeat every 6 months
Pepti7Subcutaneous250 mcg (0.25 mL of a 1 mg/mL vial) a dayOnce daily, Monday to Friday, continuing month to month

None of the eight largest peptide telehealth companies publishes a Thymalin protocol; the doses above come from smaller clinics789. No trial has set a Thymalin dose outside Russia, and clinic doses are not trial results. Clinic cautions are under side effects.

Need to calculate a dose?

Use the Prof. Peptide dosage calculator for accurate reconstitution and dosing math.

Open Calculator

How is Thymalin taken?

Thymalin is given by injection, in short daily courses678.

  • Subcutaneous injection: how clinics prescribe it, once a day through a short course or five days a week78.
  • Intramuscular injection: the route on its Russian label, the powder dissolved in 1 to 2 mL of saline before each dose6.

The peptide dosage calculator works out how much bacteriostatic water to add to a research-grade vial and how many syringe units a given amount takes. It does not set a dose.

What are the side effects of Thymalin?

Thymalin's Russian label lists allergic reactions as its only side effect6. Clinics list mild redness or swelling at the injection site, temporary fatigue or headache, and, uncommonly, mild nausea7. Its human-study abstracts give no adverse-event rates12, so the clinic and label lists are reports, not measured rates.

Clinics exclude people with active or past cancer unless an oncologist approves, those who are pregnant or breastfeeding, and those with severe kidney or liver disease7; one also excludes known hypersensitivity to thymic peptides or bovine-derived products10.

Is Thymalin legal?

Thymalin is a prescription medicine in Russia, made by Samson-Med6. It is not FDA-approved, and it is on none of FDA's compounding lists: not the list of bulk substances that may present significant safety risks11, not the 503A nomination categories12, and not among the seven substances before FDA's July 2026 compounding advisory committee13.

A clinic states it was approved as an immunomodulator by the USSR Ministry of Health in 19829. Clinics prescribe it78; research-grade Thymalin is sold for laboratory use only.

Human ObservationalLevel 3 of 4
Prof. Peptide's evidence level records the highest study design used, not whether results were good. For Thymalin that is human observational reports, none described as randomized12.

What do human studies show about Thymalin?

Thymalin's human evidence is two reports from its developers' group: 266 older people given Thymalin, Epithalamin or both for the first 2 to 3 years of a 6-to-8-year follow-up1, and COVID-19 patients given it with standard care2. Neither abstract describes randomization or blinding or gives adverse-event rates.

  • Khavinson & Morozov 2003: mortality 2.0 to 2.1 times lower in the Thymalin group, 1.6 to 1.8 times in the Epithalamin group and 2.5 times with both, against controls; 4.1 times lower in a separate group given both each year for 6 years; 2.0 to 2.4 times fewer acute respiratory infections; no dose in the abstract1.
  • Khavinson et al. 2021: COVID-19, Thymalin added to standard therapy; faster fall in IL-6, C-reactive protein and D-dimer; no patient numbers or design in the abstract2.

What does animal and lab research show about Thymalin?

Thymalin's lab and animal work: in rats with transplanted sarcoma, doses below the therapeutic range stopped or shrank tumors in more than half of the animals4, and in human stem cells grown in a dish it drove differentiation toward immune cells and raised CD28, a molecule involved in antiviral immunity3.

Its active dipeptides are reported to act on immune cells and blood vessels5. Animal and lab results do not show the same in people.

Thymalin FAQ

Does Thymalin work?

Thymalin's human reports are not described as randomized in the abstracts read. In 266 older people followed for 6 to 8 years, mortality was 2.0 to 2.1 times lower in the Thymalin group than in controls1, and in COVID-19, adding it to standard care sped the fall in inflammation markers2. See What do human studies show about Thymalin?

Is Thymalin the same as Thymogen?

No. Thymalin is a polypeptide extract of the thymus3; Thymogen is one synthetic dipeptide, Glu-Trp. Glu-Trp is reported to be one of Thymalin's active parts, with Lys-Glu5. Thymogen was tested as IM862 in cancer trials; Thymalin's human reports are in aging and COVID-1912. See What is Thymalin?

Where can I buy Thymalin?

Thymalin is a prescription medicine in Russia6 but is not approved in the US, so no US prescription product exists. Research-grade material is sold by vendors for laboratory use only. Where to buy Thymalin? lists vendors with Prof. Peptide's code, and How much does Thymalin cost? compares prices. The verified discount codes page lists every vendor with a code.

References

Show all references

  1. Peptides of pineal gland and thymus prolong human lifeHuman studyKhavinson VKh, Morozov VG. Neuro Endocrinol Lett. 2003. Abstract read November 3, 2026.Key finding: 266 elderly people over 6–8 years; bioregulators applied for the first 2–3 years; mortality “2.0-2.1-fold in the Thymalin-treated group”; a separate combination group's mortality “decreased 4.1 times as compared to the control”; 2.0–2.4-fold lower acute respiratory disease incidence. Re-read at PubMed November 5, 2026.PubMed 14523363 →
  2. Results and Prospects of Using Activator of Hematopoietic Stem Cell Differentiation in Complex Therapy for Patients with COVID-19Human studyKhavinson VK, Kuznik BI, Trofimova SV, et al. Stem Cell Rev Rep. 2021. Abstract read November 3, 2026.Key finding: Adding thymalin to standard therapy accelerated the decline in IL-6, C-reactive protein and D-dimer; no patient numbers or design in the abstract.PubMed 33575961 →DOI →
  3. Thymalin: Activation of Differentiation of Human Hematopoietic Stem CellsLab studyKhavinson VK, Linkova NS, Kvetnoy IM, et al. Bull Exp Biol Med. 2020. Abstract read November 3, 2026.PubMed 33237528 →DOI →
  4. Effect of Thymalin on the Tumor and Thymus under Conditions of Activation Therapy In VivoAnimal studyZhukova GV, Schikhlyarova AI, Barteneva TA, et al. Bull Exp Biol Med. 2018. Abstract read November 3, 2026.PubMed 29797130 →DOI →
  5. The Influence of KE and EW Dipeptides in the Composition of the Thymalin Drug on Gene Expression and Protein Synthesis Involved in the Pathogenesis of COVID-19Lab studyLinkova N, Khavinson V, Diatlova A, et al. Int J Mol Sci. 2023. Abstract read November 3, 2026.PubMed 37686182 →DOI →
  6. Тималин (Thymalin): instructions for useDrug labelOOO Samson-Med, St Petersburg. Prescribing information dated October 1, 2011, as published by medi.ru. Read in Russian November 5, 2026.Key finding: Lyophilisate for intramuscular injection, 10 mg thymus polypeptides and 20 mg glycine per vial; adults 5–20 mg daily (30–100 mg per course) for 3–10 days, repeated after 1–6 months if needed; prevention 5–10 mg daily for 3–5 days; side effects: allergic reactions; prescription only.medi.ru →
  7. ThymalinTelehealthPepti. Read November 5, 2026. Cited for its own published dose, schedule, side effects and contraindications.hellopepti.com →
  8. Boost your immunity and defy aging with ThymalinClinicHunter Williams Health, library article. Read November 5, 2026. Cited for its published dose and course only; parts of the article's text are garbled.hunterwilliamshealth.com →
  9. Peptide therapyClinicAMT Care. Read November 5, 2026. Cited for its Thymalin dose and course and its statement on the 1982 USSR approval.amtcare.com →
  10. ThymalinClinicParagon Sports Medicine. Read November 5, 2026. Cited for its evidence caution and contraindications.Key finding: “The evidence base comes largely from a single Russian research programme and does not meet modern controlled-trial standards.”paragonsportsmedicine.com →
  11. Certain bulk drug substances for use in compounding that may present significant safety risksRegulatorUS Food and Drug Administration. Page read November 5, 2026; Thymalin is not listed.fda.gov →
  12. 503A bulk drug substances nominated: Categories 1, 2 and 3 (updated May 14, 2026)RegulatorUS Food and Drug Administration. The list was read November 5, 2026; Thymalin is in none of the three categories.fda.gov →
  13. Pharmacy Compounding Advisory Committee, July 23-24, 2026: final agendaRegulatorUS Food and Drug Administration. Agenda read November 5, 2026; it lists seven bulk substances, and Thymalin is not among them.fda.gov →

Affiliate disclosure: Prof. Peptide earns a commission on purchases and sign-ups made through its links and codes, at no extra cost to the buyer. Commissions never decide which vendors are listed, how they are ranked or verified, or what Prof. Peptide concludes.

Have a question about Thymalin? Send us an email

Checked and updated